Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zuoqing San (also known as Zuoqing Granule or ZQG) is a traditional Chinese medicine (TCM) formula developed by The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine for the treatment of postoperative wound healing in patients with anal fistula. The formulation is typically composed of five herbal ingredients: Indigo Naturalis, Cortex Phellodendri, Radix Sophorae Flavescentis, Herba Agrimoniae, and Radix Sanguisorbae. It is administered topically as a fumigation and washing treatment. Zuoqing San works by suppressing pathological neutrophil extracellular trap (NET) formation through the inhibition of the Nox4/ROS/PI3K/Akt/PADI4 signaling pathway. Preclinical studies have demonstrated its ability to accelerate wound closure, resolve inflammation, and reduce bacterial burden by significantly suppressing NETosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zuoqing San (42f3f2).